ATIM-21. THE CURRENT STATUS OF AD-SGE-REIC GENE THERAPY FOR MALIGNANT GLIOMA

INTRODUCTION: Expression of the gene encoding reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) was reported to be reduced in a variety of human cancer cells. We previously examined the antitumor effect of an adenoviral vector carrying REIC/Dkk-3 gene (Ad-CAG-REIC). Recently, a novel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Kurozumi, Kazuhiko, Fujii, Kentaro, Oka, Tetsuo, Shimazu, Yosuke, Hattori, Yasuhiko, Tomita, Yusuke, Uneda, Atsuhito, Matsumoto, Yuji, Tsuboi, Nobushige, Kaneda, Keisuke, Makino, Keigo, Michiue, Hiroyuki, Kumorn, Hiromi, Date, Isao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Adult Clinical Trials–Immunologic
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847855/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.020
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia